NLRP1 and chronic myelogenous leukemia, BCR-ABL1 positive: Primary cells obtained from CML patients exhibited increased expression of IRE1α and activated NLRP1 inflammasome, whereas inhibition of IRE1α or NLRP1 led to reduced proliferation and increased apoptosis of primary CML cells.